Human medicines European public assessment report (EPAR): Ibuprofen Gen.Orph, ibuprofen, Date of authorisation: 16/02/2024, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 8, Status: Authorised
PSUSA/00009225/202506
PSUSA/00000080/202506
Herbal medicinal product: Ribis nigri folium, Ribes nigrum L., P: Draft published
Draft European Union herbal monograph on Ribes nigrum L., folium - Revision 2
Veterinary medicines European public assessment report (EPAR): Emepax, maropitant, Status: Opinion
Summary of opinion: Suvaxyn PRRS MLV, 12/02/2026 Positive
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 February 2026
Summary of opinion: Bluevac BTV (previously Bluevac BTV8), 12/02/2026 Positive